150 related articles for article (PubMed ID: 19605510)
1. Prevalence of paraneoplastic hyperthyroidism in patients with metastatic non-seminomatous germ-cell tumors.
Oosting SF; de Haas EC; Links TP; de Bruin D; Sluiter WJ; de Jong IJ; Hoekstra HJ; Sleijfer DT; Gietema JA
Ann Oncol; 2010 Jan; 21(1):104-8. PubMed ID: 19605510
[TBL] [Abstract][Full Text] [Related]
2. Hyperthyroidism in men with germ cell tumors and high levels of beta-human chorionic gonadotropin.
Giralt SA; Dexeus F; Amato R; Sella A; Logothetis C
Cancer; 1992 Mar; 69(5):1286-90. PubMed ID: 1371235
[TBL] [Abstract][Full Text] [Related]
3. [Two Cases of Germ Cell Tumors with Hyperthyroidism Due to High Serum hCGLevels].
Chihara I; Nitta S; Kimura T; Kandori S; Kawahara T; Waku N; Kojima T; Joraku A; Miyazaki J; Iwasaki H; Suzuki H; Kawai K; Nishiyama H
Hinyokika Kiyo; 2016 Sep; 62(9):489-493. PubMed ID: 27760975
[TBL] [Abstract][Full Text] [Related]
4. Human chorionic gonadotropin-induced hyperthyroidism in germ cell cancer--a case presentation and review of the literature.
Voigt W; Maher G; Wolf HH; Schmoll HJ
Onkologie; 2007 Jun; 30(6):330-4. PubMed ID: 17585415
[TBL] [Abstract][Full Text] [Related]
5. The usefulness of testosterone administration in identifying false-positive elevation of serum human chorionic gonadotropin in patients with germ cell tumor.
Takizawa A; Kawai K; Kawahara T; Kojima T; Maruyama S; Shinohara N; Akamatsu S; Kamba T; Nakamura T; Ukimura O; Jikuya R; Kishida T; Kakimoto K; Nishimura K; Harabayashi T; Nagamori S; Yamashita S; Arai Y; Sawada Y; Sekido N; Kinoshita H; Matsuda T; Nakagawa T; Homma Y; Nishiyama H
J Cancer Res Clin Oncol; 2018 Jan; 144(1):109-115. PubMed ID: 28905168
[TBL] [Abstract][Full Text] [Related]
6. Paraneoplastic Hyperthyroidism Secondary to a Chemotherapy-Induced Surge in β-hCG in a Patient with Non-Seminomatous Germ Cell Tumor.
Erol LA; Layman CP
Hawaii J Health Soc Welf; 2024 Feb; 83(2):45-47. PubMed ID: 38344694
[TBL] [Abstract][Full Text] [Related]
7. Thyroid storm as an early presentation of hCG-producing metastatic choriocarcinoma: a case report and review of the literature.
Chivukula KK; Toro-Tobón D; Motazedi B; Goyal R
BMJ Case Rep; 2021 Sep; 14(9):. PubMed ID: 34580125
[TBL] [Abstract][Full Text] [Related]
8. Semen quality and reproductive hormones before orchiectomy in men with testicular cancer.
Petersen PM; Skakkebaek NE; Vistisen K; Rørth M; Giwercman A
J Clin Oncol; 1999 Mar; 17(3):941-7. PubMed ID: 10071288
[TBL] [Abstract][Full Text] [Related]
9. Metastatic non-seminomatous germ cell tumour and dermatomyositis.
Barker RA; Currie DC; Horwich A; Spiro SG
Postgrad Med J; 1990 Jan; 66(771):59-60. PubMed ID: 1693426
[TBL] [Abstract][Full Text] [Related]
10. Molecular heterogeneity of human chorionic gonadotropin and its subunits in testicular cancer.
Mann K; Karl HJ
Cancer; 1983 Aug; 52(4):654-60. PubMed ID: 6305481
[TBL] [Abstract][Full Text] [Related]
11. Prognostic implications of tumour marker analysis in non-seminomatous germ cell tumours with poor prognosis metastatic disease.
Gerl A; Clemm C; Lamerz R; Mann K; Wilmanns W
Eur J Cancer; 1993; 29A(7):961-5. PubMed ID: 7684597
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of pregnancy-specific beta 1-glycoprotein in patients with non-seminomatous testicular germ cell tumors.
de Bruijn HW; Suurmeijer AJ; Sleijfer DT; Koops HS; Ockhuizen T; Willemse PH; Marrink J
Eur J Cancer Clin Oncol; 1982 Oct; 18(10):911-6. PubMed ID: 6186495
[TBL] [Abstract][Full Text] [Related]
13. Symptomatic hyperthyroidism in metastatic testicular mixed germ cell tumour.
Shah D; Khalid N
BMJ Case Rep; 2018 Jun; 2018():. PubMed ID: 29884717
[TBL] [Abstract][Full Text] [Related]
14. Thyroid function in choriocarcinoma: demonstration of a thyroid stimulating activity in serum using FRTL-5 and human thyroid cells.
Kennedy RL; Sheridan E; Darne J; Griffiths H; Davies R; Price A; Cohn M
Clin Endocrinol (Oxf); 1990 Aug; 33(2):227-37. PubMed ID: 2225480
[TBL] [Abstract][Full Text] [Related]
15. Predictive value of modeled AUC(AFP-hCG), a dynamic kinetic parameter characterizing serum tumor marker decline in patients with nonseminomatous germ cell tumor.
You B; Fronton L; Boyle H; Droz JP; Girard P; Tranchand B; Ribba B; Tod M; Chabaud S; Coquelin H; Fléchon A
Urology; 2010 Aug; 76(2):423-9.e2. PubMed ID: 20472276
[TBL] [Abstract][Full Text] [Related]
16. Hyperthyroidism from an embryonal carcinoma.
Gama R; Smith MG; White WF; Kwong P
J R Soc Med; 1997 Aug; 90(8):446-7. PubMed ID: 9307000
[No Abstract] [Full Text] [Related]
17. Hyperthyroidism in non-seminomatous testicular germ cell tumors: two case reports and literature review.
Favero D; Oing C; Seidel C; Rescigno P; Catalano F; Cremante M; Rebuzzi SE; Gatto F; Rosti G; Ferone D; Fornarini G; Cocchiara F
Front Oncol; 2024; 14():1338438. PubMed ID: 38601761
[TBL] [Abstract][Full Text] [Related]
18. Non-seminomatous germ cell tumors of the testis. Immunohistochemical localization and serum levels of human chorionic gonadotropin (HCG) and pregnancy-specific beta-1 glycoprotein (SP-1); value of SP-1 as a tumor marker.
Suurmeijer AJ; De Bruijn HW; Oosterhuis JW; Sleyfer DT; Koops HS; Fleuren GJ
Oncodev Biol Med; 1982; 3(5-6):409-22. PubMed ID: 6292873
[TBL] [Abstract][Full Text] [Related]
19. [Paraneoplastic hyperthyroidism in a patient with metastasizing teratocarcinoma and excessively high HCG].
Berdjis N; Baldauf A; Kittner T; Manseck A; Wirth M
Aktuelle Urol; 2003 Oct; 34(6):407-9. PubMed ID: 14579189
[TBL] [Abstract][Full Text] [Related]
20. [A CASE OF ADVANCED NON-SEMINOMATOUS TESTICULAR GERM CELL TUMOR ACCOMPANIED PANIC DISORDER].
Okumura A; Morii A; Kiriyama M; Takamatsu H; Shimizu M; Yasui S; Takagawa K
Nihon Hinyokika Gakkai Zasshi; 2016; 107(1):48-53. PubMed ID: 28132992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
